12805 Lockwood Rd - Site 5

BioHub Two’s master plan is comprised of over 500,000 square feet for cGMP manufacturing, wet and dry labs, and office space located in Generation Park, with nearly $30 million in infrastructure nearing completion to serve the new site. Generation Park is one of the world’s largest privately held commercial developments in the country’s most diverse city, Houston, TX. You’ll be surrounded by forward thinking companies and have direct access to workforce training programs at San Jacinto College and Lone Star College.
BioHub Two’s 45-acres can be subdivided to accommodate the full spectrum of life science uses including small and large-scale pharmaceutical and medical device manufacturing needs. Adjacent to the BioHub sites are plans for two multi-family communities and The Commons, a 5-acre green space with freestanding opportunities for small-format restaurants and cafes. Future tenants will have direct access to workforce training programs at San Jacinto College and Lone Star College. Employees and guests will be linked to retail amenities and beautiful parks via The Ray, a looping pedestrian superhighway that connects all of Generation Park West.
BioHub Two neighbors San Jacinto College’s Center for Biotechnology at Generation Park, in partnership with the National Institute of Biotechnology Research and Training (NIBRT). NIBRT is globally recognized as the gold standard in training and research solutions for the biopharmaceutical manufacturing industry. San Jacinto College, nationally recognized as one of the country’s best community colleges, will open a brand-new Center for Biotechnology at San Jacinto College’s Generation Park campus in Q1 2025. This state-of-the-art facility will provide comprehensive, hands-on training with realistic good manufacturing practices (GMP) simulated environments and offer an associate of applied science degree in biomanufacturing technology, and shorter credentials for post-graduates, to meet workforce needs.
A 2022 study from The Greater Houston Partnership identified Houston as a prime hub for cell and gene therapy R&D and manufacturing, cancer-focused molecular diagnostics within R&D and production, and biologics drug development and manufacturing. Houston has cultivated a fast-growing life science ecosystem: there are over 700 life science companies, a core life science workforce totaling 26,000, 5,000 active clinical trials and is ranked tenth in the Top 20 US Metros for Life Science Companies. Houston is ranked third in the US metro for business expansion and relocation and is included in the top 25 global cities of the future.